Brief: Redcare Pharmacy Q3 RX Sales in Germany grow 81%
Nov 5 (Reuters) - REDCARE PHARMACY NV RDC.DE :
* GROWTH IN Q3 WITH AN ADJUSTED EBITDA MARGIN OF 2%
* TOTAL GROUP SALES GROWTH 21% IN Q3 TO EUR 575M
* RX SALES GROWTH 23% IN Q3 TO EUR 191M (9M INCREASE 80% TO
EUR
518M)
* RX SALES IN GERMANY GREW 81% IN Q3 TO 69M, 130% IN OCTOBER
AS
PART OF Q4
* CONFIRMS FY 2024 GUIDANCE
Further company coverage: RDC.DE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))